Supreme Court Declines to Resolve Divisive False Claims Act Issue

Earlier this month, the Supreme Court denied certiorari in United States ex rel. Laurence Schneider, et al. v. JPMorgan Chase Bank, refusing to decide whether the federal government is entitled to absolute deference regarding its decision to dismiss an action brought pursuant to the False Claims Act (“FCA”). The FCA deputizes private citizens to stand […]

Pennsylvania Federal Judge Rules That PharMerica Can’t Escape FCA Lawsuit

Authors: John Roberts (jroberts@sfmslaw.com) or Alec Berin (aberin@sfmslaw.com) On February 5th, U.S. District Judge Cynthia M. Rufe of the Eastern District of Pennsylvania denied PharMerica Corporation’s (“PharMerica”) motion to dismiss a complaint that alleges it violated the False Claims Act (“FCA”). The complaint, filed by four relators who were former employees of PharMerica, contends that […]

Florida and New York Classes Recommended for Certification in Gerber False Advertising Action

On February 20, 2019, Magistrate Judge Ramon E. Reyes, Jr., of the United States District Court for the Eastern District of New York, found that the proposed classes of New York and Florida consumers of Gerber Products Co.’s (“Gerber”) Good Start Gentle baby-formula satisfied their state law requirements, while proposed North Carolina and multistate classes […]

SFMS Logo

Detroit Hospital System to Settle FCA Kickback Allegations for $84.5 Million

The U.S. Department of Justice (“DOJ”) announced on August 2, 2018, that Beaumont Health (“Beaumont”), a Detroit area hospital system, has agreed to an $84.5 million settlement to resolve a case setting forth False Claims Act (“FCA”) allegations that it defrauded Medicare, Medicaid, and Tricare by paying kickbacks to physicians in return for false billing […]

SFMS Logo

Florida Health Care Group Pays $1.7 Million Settlement in Medicare False Claims Suit

The U.S. Department of Justice (“DOJ”) announced on July 2, 2018, that FWC Urogynecology LLC (“FWC”), a network of urogynecologists in Florida, has agreed to pay $1.7 million to settle claims that it violated the False Claims Act (“FCA”). The United States notified the court of its intent to intervene and prosecute the suit on […]

SFMS Logo

Ambulance Company Kickbacks Result In $8.6 Million Settlement For HCA-Affiliated Hospitals

On October 4, 2017, the U.S. Department of Justice announced that four hospitals in the Houston, TX area affiliated with HCA Holdings, Inc. (“HCA”) will pay an $8.6 million settlement regarding a False Claims Act (“FCA”) suit. The hospitals, Bayshore Medical Center, Clear Lake Regional Medical Center, West Houston Medical Center, and East Houston Regional […]

SFMS Logo

FCA Suit Against HealthMarkets Dismissed

U.S. District Judge Mary S. Scriven dismissed a suit brought against HealthMarkets Inc. (“HealthMarkets” or the “Company”) by an anonymous whistleblower (“John Doe” or “Doe”) on May 23, 2017, after the federal government declined to intervene and John Doe dropped the suit. In the complaint, originally filed under seal in April 2016, Doe accused the […]

SFMS Logo

PA Doctors Motion for Summary Judgment after Third Circuit Ruling

The False Claims Act (“FCA”) requires a materiality to establish a claim for liability, and defines “material” as a natural tendency or capability to influence a bribe. Earlier this year, the Third Circuit applied a stricter materiality standard in United States ex rel. Petratos v. Genentech Inc. (“Petratos“), 855 F.3d 481 (3d Cir. 2017). The […]

SFMS Logo

Anham Fights Against False Claims Allegations

In 2014, Anham FZCO (“Anham”), a United Arab Emirates-based food supply contractor for the U.S. military in Afghanistan, was accused of misleading the government about the construction of a warehouse and its transportation of goods through Iran. Anham currently holds an $8.1 billion vendor contract with the U.S. Department of Defense (“DOD”). One of Anham’s […]

SFMS Logo

Allergan Kickback Claims Survive Provisional Stage

John Wood (“Wood”) served as a senior territory manager for Allergan Inc. (“Allergan” or the “Company”) from October 2008 through July 2010, during which time he became privy to the allegedly illegal practice of bribing physicians to prescribe Allergan drugs in exchange for $100 million worth of drug samples and other goods. Once Wood internally […]

A Message to Our Clients About Coronavirus COVID-19:
PLEASE READ »

A Message to Our Clients About Coronavirus COVID-19

At Shepherd, Finkelman, Miller & Shah, LLP, we view the safety and well-being of our clients, staff and business partners as our highest priority.

The situation regarding the COVID-19 virus is continually changing, and we are following all recommended guidelines to stay healthy. As a result, our lawyers and staff are working remotely in accordance with the CDC's recommendations. We continue to work for all of our clients and are happy to arrange for phone or video consultations. We are also able to exchange documents via secure drives or email.

Please contact us online or call 866-540-5505 with any questions.

Thank you and take care.